We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Emergency Alerts Test on Sunday 7 September, 3pm
This literature review reports on the available published evidence on menopause in the workplace with regard to individual experience, employer support, and the associated cost to the UK economy
Thousands of women are set to benefit from plans to boost workplace support as leaders from across industry, healthcare and the legal profession came together today to form the first-ever independent Menopause Advisory Group.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 8 July, become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause.
Ambassador to work with employers to help women experiencing menopause symptoms to stay in work and progress in their careers.
Science advice note: What evidence is there on the relationship between access to/uptake of individual health interventions for menopause and workplace productivity?
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).